Fortis Healthcare Faces GST Orders Totaling ₹21.49 Crore
Fortis Healthcare received GST orders for FY21, FY22, and FY23. The confirmed demands, including interest and penalties, total ₹4.78 crore for FY21, ₹8.50 crore for FY22, and ₹8.12 crore for FY23, amounting to a total of ₹21.40 crore. Show cause notices for remaining amounts were dropped.
The confirmed GST demands, including interest and penalties, represent a significant financial obligation for the company, impacting its profitability and cash flow.
The company has received GST orders confirming demands which include penalties and interest, indicating a negative financial impact.
Fortis Healthcare Limited has announced that it is in receipt of Goods and Services Tax (GST) orders for the financial years 2020-21, 2021-22, and 2022-23. The State Tax Officer, Chengalpattu, Intelligence Division, Tamil Nadu, had initially issued show cause notices for amounts including penalties. For FY 2020-21, the initial notice was for ₹469.63 lakhs, with ₹234.82 lakhs being penalty. For FY 2021-22, the notice was for ₹678.09 lakhs, with ₹339.04 lakhs as penalty. For FY 2022-23, the notice was for ₹668.83 lakhs, with ₹334.41 lakhs as penalty.
Following the company's response, the GST Authority has passed orders confirming demands. For FY 2020-21, the confirmed demand is ₹478.08 lakhs, which includes interest and penalty of ₹142.02 lakhs and ₹168.03 lakhs, respectively. For FY 2021-22, the confirmed demand is ₹850.00 lakhs, including interest and penalty of ₹212.16 lakhs and ₹318.92 lakhs, respectively. For FY 2022-23, the confirmed demand is ₹811.53 lakhs, including interest and penalty of ₹158.58 lakhs and ₹326.47 lakhs, respectively. The show cause notices pertaining to the balance amounts have been dropped by the GST Authority.
The events related to these orders occurred on December 29, 2025, at 5:46 PM for FY 2020-21, December 29, 2025, at 5:53 PM for FY 2021-22, and December 30, 2025, at 4:38 PM for FY 2022-23.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.